Current Report Filing (8-k)
May 08 2019 - 4:17PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.
20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
May 7, 2019
Date of Report (Date of Earliest
Event Reported)
INTELGENX TECHNOLOGIES CORP.
(Exact Name of Registrant as Specified in its Charter)
Delaware
|
000-31187
|
870638336
|
(State or other jurisdiction of
|
(Commission File
|
(IRS Employer Identification
|
incorporation)
|
Number)
|
No.)
|
6420 Abrams, Ville St- Laurent, Quebec,
Canada
H4S 1Y2
(Address of principal
executive offices) (Zip Code)
Registrant's telephone number, including area code:
(514)
331-7440
Check the appropriate box below if the Form 8K fining is
intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
[ ] Written communications pursuant to Rule 425
under the Securities Act (17CFR230.425)
[ ] Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a -12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d -2(b))
[ ]
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e -4(c))
Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the
Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b -2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to
Section 13(a) of the Exchange Act.[ ]
Item 5.02.
Appointment of Certain Officer.
IntelGenx Technologies Corp. (IntelGenx), announced today,
that its Board of Directors appointed André Godin to the position of President
in addition to his current position as the Companys Chief Financial
Officer.
In his newly expanded role, Mr. Godin will have overall
responsibility for day-to-day operations, financial reporting and budgeting, as
well as managing the Company's relationships and interactions with the
investment community. He will continue to report to the Companys CEO, Dr. Horst
G. Zerbe.
Mr. Godin has an accomplished history of financial and
operational leadership success in the life sciences industry. In an executive
management career that spans close to three decades, he most recently served as
IntelGenxs Executive Vice-President and Chief Financial Officer. Before joining
IntelGenx in 2015, he was Interim CEO and CFO of Neptune Technologies and
Bioresources Inc. He started with Neptune in 2003 as Vice President,
Administration and Finance and was named its CFO in 2008. Prior to joining
Neptune, he was President of a dietary supplement company and Corporate
Controller for an OTC pharmaceutical products company. Mr. Godin is a member of
the Canadian Chartered Professional Accountants and the Canadian Institute of
Chartered Accountants. He holds a Bachelor of Business Administration degree
from Université du Québec à Montreal.
Item 8.01 Other
Events
.
On May 8, 2019, the Company issued a press release announcing
the appointment of Andre Godin. A copy of the press release is attached hereto
as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
INTELGENX TECHNOLOGIES CORP.
|
Dated: May 8, 2019
|
By: /s/
Horst G. Zerbe
|
|
Horst G. Zerbe
|
|
Chief Executive Officer
|
IntelGenx Technologies (CE) (USOTC:IGXT)
Historical Stock Chart
From Aug 2024 to Sep 2024
IntelGenx Technologies (CE) (USOTC:IGXT)
Historical Stock Chart
From Sep 2023 to Sep 2024